Biofilms and infection in dialysis patients

Seminars in Dialysis

Volumn 15, Issue 5, 2002, Pages 338-346

  Dasgupta, Mrinal K ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

BACTERIAL INFECTION; BIOFILM; CHRONIC KIDNEY FAILURE; EQUIPMENT; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH, DEVELOPMENT AND AGING; HUMAN; INDWELLING CATHETER; MALE; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PERITONEAL DIALYSIS; PHYSIOLOGY; PRIMARY PREVENTION; PROGNOSIS; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOFILMS; CATHETERS, INDWELLING; EQUIPMENT CONTAMINATION; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MICROBIAL SENSITIVITY TESTS; PERITONEAL DIALYSIS; PRIMARY PREVENTION; PROGNOSIS; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 0036719602     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1046/j.1525-139X.2002.00084.x     Document Type: Review

References (88)

1. Costerton JW, Cheng KJ, Geesy GG, Ladd TI, Nickel JC, Dasgupta MK Marrie TJ: Bacterial biofilms in nature and disease. Ann Rev Microbiol 41:435-464, 1987
2. Dasgupta MK, Costerton JW: Significance of biofilm-adherent bacterial microcolonies on Tenckhoff catheters of CAPD patients. Blood Purif 7:144-155, 1989
3. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322, 1999
4. Donlan RM: Biofilms and device-associated infections. Emerg Infect Dis 7:277-281, 2001
5. Man NK, Degremont A, Darbord JC, Collet M, Vaillant P: Evidence of bacterial biofilm in tubing from hydraulic pathway of hemodialysis system. Artif Organs 22:596-600, 1998
6. Phillips G, Hudson S, Stewart WK: Persistence of microflora in biofilm within fluid pathways of contemporary haemodialysis monitors (Gambro AK-10). J Hosp Infect 27:117-125, 1994
7. Maar KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB: Catheter-related bacteraemia and outcome of attempted catheter salvage in patients undergoing haemodialysis. Ann Intern Med 15:275-280, 1998
8. Raad II: The pathogenesis and prevention of central venous catheter-related infections. Middle East J Anaesthesiol 12:381-403, 1994
9. Dasgupta MK, Kowalewska-Grochowska K, Larabie M, Costerton JW: Catheter biofilms and recurrent CAPD peritonitis. Adv Perit Dial 7:169-172, 1991
10. Sheth NK, Franson TR, Rose HD, Buckmire FL, Cooper JA, Sohnle PG: Colonization of bacteria on polyvinyl chloride and Teflon intravascular catheter in hospitalized patients. J Clin Microbiol 18:1061-1063, 1983
11. Rotrosen D, Calderone RA, Edwards JE: Adherence of Candida species to host tissues and plastic surfaces. Rev Infect Dis 8:73-85, 1986
12. Anderson JE, Chang ASY, Anstadt MP: Polytetrafluoroethylene haemoaccess site infections. ASAIO J 46:S18-S21, 2000
13. Bellon JM, G-Honduvilla N, Jurado F, Carranza A, Bujan J: In vitro interreaction of bacteria with polypropylene/ePTFE prostheses. Biomaterials 22:2021-2024, 2001
14. Hoen B, Dauphin AP, Hestin D, Kessler M: EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic haemodialysis patients. J Am Soc Nephrol 9:869-876, 1998
15. Butterly DW, Schwab SJ: Dialysis access infections. Curr Opin Nephrol Hypertens 9:631-635, 2000
16. Passerini L, Lam K, Costerton JW, King EG: Biofilms on indwelling vascular catheters. Crit Care Med 20:665-673, 1992
17. Anaissie E, Samonis G, Kontoyiannis D, Costerton J, Sabharwal U, Bodey G, Raad I: Role of catheter colonization and infrequent haematogenous seedine in catheter-related infections. Eur J Clin Microbiol Infect Dis 14:134-137, 1995
18. Raad I, Costerton JW, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP: Ultrastructure analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168:400-407, 1993
19. Kowalewska-Grochowska K, Richards R, Moysa GL, Lam K, Costerton JW, King EG: Guidewire catheter change in central venous catheter biofilm formation in a burn population. Chest 100:1090-1095, 1991
20. Mohammad SF: Enhanced risk of infection with device-associated thrombi. ASAIO J 46:S63-S68, 2000
21. Hung KY, Tsai TJ, Yen CJ, Yen TS: Infections associated with double-lumen catheterization for temporary haemodialysis experience of 168 cases. Nephrol Dial Transplant 10:247-251, 1995
22. Saad TF: Bacteraemia associated with tunneled-cuffed haemodialysis catheters. Am J Kidney Dis 34:1114-1124, 1999
23. Taylor GD, McKenzie M, Buchanan-Chello L, Chui L: Central venous catheters as a source of haemodialysis related bacteraemia. Infect Control Hospital Epidemiol 19:643-646, 1998
24. Olson ME, Lam K, Bodey GF, King EG, Costerton JW: Evaluation of strategies for central venous catheter replacement. Crit Care Med 20:797-804, 1992
25. Vincent FC, Tibi AR, Darbord JC: A bacterial biofilm in a haemodialysis system. Assessment of disinfection and crossing of endotoxin. ASAIO Trans 35:310-313, 1989
26. Morin P: Identification of the bacteriological contamination of a water treatment line used for haemodialysis and its disinfection. J Hosp Infect 45:218-224, 2000
27. Du Moulin GC, Coleman EC Jr, Hedley-White J: Bacterial colonization and endotoxin content of a new renal dialysis water system composed of acrylonitrile butadiene styrene. Appl Environ Microbiol 53:1322-1326, 1987
28. Cappelli G, Perrone S, Ciufireda A: Water quality for on-line haemodiafiltration. Nephrol Dial Transplant 13(suppl 5):12-16, 1998
29. Mazaud P: Monitoring the microbiological quality of hemodialysis fluids. Pathol Biol (Paris) 48:784-787, 2000
30. Ledebo I, Nystrand R: Defining the microbioloacal quality of dialysis fluid. Artif Organs 23:37-43, 1999
31. Ronco C, Cappelli G, Ballestri M, Lusvarghi E, Frisone P, Milan M, et al.: On line filtration of dialysate: structural and functional features of an asymmetric polysulfone hollow fiber ultrafilter (Diaclean). Int J Artif Organs 17:515-520, 1994
32. Henderson LW, Bears E: Successful production of sterile pyrogenfree electrolyte solutions by ultrafiltration. Kidney Int 14:522-524, 1978
33. Capelli G, Tetta C, Cornia F, Di Felice A, Facchini F, Neri R, Lucchi L, Lusvarghi E: Removal of limulus reactivity and cytokine inducing capacity from bicarbonate dialysis fluids by ultrafiltration. Nephrol Dial Transplant 8:1133-1139, 1993
34. Frinak S, Polasachegg HD, Levin NW, Pohlod DJ, Dumler F, Saravolatz LD: Filtration of dialysate using an on line dialysate filter. Int J Artif Organs 14:601-607, 1991
35. Gorman SP, Mawhinney WM, Adair CG, Issouckis M: Confocal laser scanning microscopy of peritoneal catheter surfaces. J Med Microbiol 38:411-417, 1993
36. Dasgupta MK, Ulan RA, Bettcher KB, Burns V, Lam K, Dossetor JB, Costerton JW: Effect of exit site infection and peritonitis on the distribution of biofilm encased adherent bacterial microcolonies (BABM) on Tenckhoff (T) catheters in patients undergoing continuous ambulatory peritoneal dialysis. Adv Perit Dial 2:102-109, 1986
37. Dasgupta MK, Bettcher KB, Ulan RA, Burns V, Lam K, Dossetor JB, Costerton JW: Relationship of adherent bacterial biofilms to peritonitis in chronic ambulatory peritoneal dialysis. Perit Dial Bull 7:168-173, 1987
38. Verger C, Chesneau AM, Thibault M, Batalie N: Biofilm on the Tenckhoff catheters: a negligible source of contamination. Perit Dial Bull 7:178-184, 1987
39. Swartz R, Messana J, I Holmes C, Williams J: Biofilm formation on peritoneal catheters does not require presence of infection. ASAIO Trans 37:626-634, 1991
40. Obst G, Gagnon RF, Harris A, Prentis J, Richards GK: The activity of rifampin and analogs against Staphylococcus epidermidis biofilm in a CAPD environment model. Am J Nephrol 9:414-420, 1989
41. Dasgupta MK, Lam K, Ulan RA, Bettcher KB, Burns V, Tyrrell DL, Dossetor JB, Costerton JW: An extracorporeal model of biofilm-adherent bacterial microcolony colonization for the study of peritonitis in continuous ambulatory peritoneal dialysis. Am J Nephrol 8:118-122, 1988
42. Dasgupta MK, Ward K, Noble PA, Larabie M, Costerton JW: Development of bacterial biofilms on silastic catheter materials in peritoneal dialysis fluid. Am J Kidney Dis 23:709-716, 1994
43. Dasgupta MK, Larabie M, Lam K, Bettcher KB, Tyrrell DL, Costerton JW: Growlh of bacterial biofilms on Tenckhoff catheter discs in vitro after simulated touch contamination of the Y-connectina set in continuous ambulatory peritoneal dialysis. Am J Nephrol 10:353-358, 1990
44. Maiorca R, Cantaluppi A, Cancarini GC, Sealamogna A, Strada A, Graziani G, Brasa S, Ponticelli C: Prospective controlled trial of Y connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1:642-644, 1983
45. The Canadian CAPD Trials Group: Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multicentre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Perit Dial Int 9:159-163, 1989
46. Dasgupta MK, Fox S, Gagnon D, Bencher KB, Ulan RA: Significant reduction of peritonitis rate by the use of twin bag system in a Canadian reaional CAPD program. Adv Perit Dial 8:223-226, 1992
47. Port FK, Held PJ, Nolph KD, Turenne MN, Wolfe RA: Risk of peritonitis and technique failure by CAPD connection techniques: a national study. Kidney Int 42:967-974, 1992
48. Kiernan L, Kliger A, Gorban-Brennan N, Juergensen P, Finkeldtein F: Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems. J Am Soc Nephrol 5:1835-1838, 1995
49. Harris DC, Yuill EJ, Byth K, Chapman JR, Hunt C: Twin- versus single-bag disconnect systems: infection rates and cost of CAPD. J Am Soc Nephrol 7:2392-2398, 1996
50. Schaubel DE, Blake PG, Fenton SA: Trends in CAPD technique failure: Canada, 1981-1997. Perit Dial Int 21:365-371, 2001
51. Anwar H, Dasgupta MK, Lam K, Costerton JW: Tobramycin resistance of mucoid Pseudomonas aeuriginosa biofilm grown under iron limitation conditions. J Antimicrob Chemother 24:647-655, 1989
52. Domingue G, Ellis B, Dasgupta M, Costerton JW: Testing antimicrobial susceptibilities of adherent bacteria by a method that incorporates guidelines of the National Committee for Clinical Laboratory Standards. J Clin Microbiol 32:2564-2568, 1994
53. Dasgupta MK, Kowalewska-Grochowska K, Costerton JW: Biofilm and peritonitis in peritoneal dialysis. Perit Dial Int 13(suppl 2):S322-S325, 1993
54. Richards GK, Gagnon RF, Prentis J: An in-vitro comparison of antibiotic kinetics against Staphylococcus biofilms. J Am Soc Nephrol 2:367, 1991
55. Dasgupta MK, Shishido H, Salama S, Singh R, Larabie M, Micetich RG: The effect of macrolide and quinolone antibiotics in methicillin-resistant Staphylococcus aureus biofilm growth. Adv Perit Dial 13:142-156, 1997
56. Keane WF, Baille GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Kawaguchi Y, Piraino B, Riella M, Vas S: ISPD guidelines/recommendations: adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int 20:396-411, 2000
57. Read RR, Eberwin P, Dasgupta MK, Grant SK, Lam K, Nickel C, Costerton JW: Peritonitis in peritoneal dialysis: bacterial colonization by biofilm spread along the catheter surface. Kidney Int 35:614-621, 1989
58. McDermid KP, Morck DW, Oison ME, Boyd ND, Khoury AF, Dasgupta MK, Costerton JW: A porcine model of Staphylococcus epidermidis catheter associated infection. J Infect Dis 168:897-903, 1993
59. Bernadini J, Piraino B, Holley J, Johnston JR, Lutes R: A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: muporicin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 27:695-700, 1996
60. Thodis E, Bhaskaran S, Pasadakis P, Bergman JM, Vas SI, Oreopoulos DG: Decrease in Staphylococcus aureus exit site infections and peritonitis in CAPD patients by local application of muporicin ointment at the catheter exit site. Perit Dial Int 18:261-270, 1998
61. Perez-Fontan M, Garcia-Falcon, Resales M, Rodriguez-Carmona A, Adera M, Rodriguez Lezano I, Monclian J. Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with muporicin: Ions-term results. Am J Kidney Dis 22:708-712, 1996
62. Yu VL, Goetz A, Wagner M, Smith PB, Rihs JD, Hanchett J, Zuravleff JJ: Staphylococcus aureus nasal carriage and infections in patients hemodialysis: efficacy of antibiotic prophylaxis. N Eng J Med 315:91-96, 1986
63. The Muporicin Study Group: Nasal muporicin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol 11:2403-2408, 1996
64. Moncrief JW, Popovich RP, Dasgupta MK, Costerton JW, Simmons E, Moncrief BA: Reduction in peritonitis incidence in continuous ambulatory peritoneal dialysis w ith a new catheter implantation technique. Perit Dial Int 13:329-331, 1993
65. Dasgupta MK, Perry D, Fox S: Exit-site infection, but not peritonitis, is reduced by the use of Moncrief-Popovich catheters in comparison to Tenckhoff catheters [abstract]. J Am Soc Nephrol 11:A1089, 2000
66. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A: The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37:1771-1776, 1999
67. Miyake Y, Fujiwara S, Usui T, Suginaka H: Simple method for measuring the antibiotic concentration required to kill adherent bacteria. Chemotherapy 38:286-290, 1992
68. Amorena B, Gracia E, Monzon M, Leira J, Oteiza C, Ferez M, Albart JL, Hernandez-Yago J: Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother 44:43-55, 1999
69. Chuard C, Vaudaux P, Waldvogel FA, Lew DP: Susceptibility of Staphylococcus aureus growing in fibronectin-coated surfaces to bactericidal antibiotics. Antimicrob Agents Chemother 37:625-632, 1993
70. Hamilton-Miller JMT, Shah S: Activity of quinuprupristin dalfopristin against Staphylococcus epidermidis in biofilms: a comparison with ciprofloxacin. J Antimicrob Chemother 39(suppl A):103-108, 1997
71. DuGuid IG, Evans E, Brown MRW, Gilbert P: Growth-rate-indepcndent killing by ciprofloxacin of biofilm-derived Staphylococcus epidermidis: evidence for cell-cycle dependency. J Antimicrob Chemother 30:791-802, 1992
72. Jouenne T, Tresse O, Junter G-A: Agar-entrapped bacteria as an in vitro model of biofilms and their susceptibility to antibiotics. FEMS Microbiol Lett 119:237-242, 1994
73. Anwar H, Dasgupta MK, Costerton JW: Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob Agents Chemother 34:2043-2046, 1990
74. de Fijter CW, ter Wee PM, Oe LP, Verburgh HA: Intraperitoneal ciprofloxacin and rifampicin versus cepharidine as initial treatment of (c)APD-related peritonitis: a prospective randomized multicenter comparison (CIPPER trial). Perit Dial Int 21:480-486, 2001
75. Worland MA, Radabaugh RS, Mueller BA: Intraperitoneal thrombolytic therapy for peritoneal dialysis associated peritonitis. Ann Pharmacother 1998 32:1216-1220
76. Dasgupta MK: Use of streptokinase or urokinase in recurrent CAPD peritonitis. Adv Perit Dial vol 7:169-172, 1991
77. Duch JM, Yee J: Successful use of recombinant tissue plasminogen activators in a patient with relapsing peritonitis. Am J Kidney Dis 37:149-153, 2001
78. Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ: Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home parenteral nutrition patients. J Parenter Enteral Nutr 12:185-189, 1988
79. Boorgu RD, Dubrow AJ, Levin NW, My H, Canaud BJ, Lentino JR, Wentworth DW, Hatch DA, Megerman J, Prosl FR, Gandhi VC, Ing TS: Adjunctive antibiotic/anticoagulant lock therapy in the treatment of bacteremia associated with the use of subcutaneously implanted hemodialysis access device. ASAIO J 46:767-770, 2000
80. Krishnasami Z, Carlton D, Bimbo L, Taylor ME, Balkovetz DF, Barker J, Allon M: Management of haemodialysis catheter-related bacteraemia with an adjunctive antibiotic lock solution. Kidney Int 61:1136-1142, 2002
81. Dasgupta MK: Exit-site and catheter related infection in peritoneal dialysis: problems and progress. Nephrology 5:17-25, 2000
82. Dasgupta MK: Silver coated catheters in peritoneal dialysis. Perit Dial Int 17(suppl 2):142-145, 1997
83. Maki DG, Cobb L, Carman JK, Shapiro JM, Ringer M, Helgerson RB: An attachable silver-impregnated cuff for prevention of infection with central venous catheter; a prospective randomized multicenter trial. Am J Med 85:307-314, 1988
84. Bambauer R, Mestres P, Sioshaansi P: New surface treated catheters for blood access. J Am Soc Nephrol 5:406, 1996
85. Francois P, Schrenzel J, Stoerman-Chopard C, Favre H, Herrmann M, Foster TJ, Lew DP, Vaudaux B: Identification of plasma proteins adsorbed on haemodialysis tubing that promote Staphylococcus aureus adhesion. J Lab Clin Med 135:32-42, 2000
86. Falkenback D, Lundberg F, Ribbe E, Ljungh A: Exposure of plasma proteins on Dacron and ePTFE vascular graft material in a perfusion model. Eur J Vasc Endovasc Surg 19:468-475, 2000
87. Green RJ, Davies MC, Roberts CJ, Tendler SJ: Competitive protein adsorption as observed by surface plasmon resonance. Biomaterials 20:385-391, 1999
88. Yanagisawa N, Li DQ, Ljungh A: The N-terminal of thrombospondin-1 is essential for coagulase negative staphylococcal binding. J Med Microbiol 50:712-719, 2001